Barclays PLC Sells 237,359 Shares of bluebird bio, Inc. (NASDAQ:BLUE)
Barclays PLC reduced its position in bluebird bio, Inc. (NASDAQ:BLUE – Free Report) by 94.2% in the fourth quarter, Holdings Channel.com reports. The firm owned 14,703 shares of the biotechnology company’s stock after selling 237,359 shares during the quarter. Barclays PLC’s holdings in bluebird bio were worth $123,000 at the end of the most recent […]
Barclays PLC reduced its position in bluebird bio, Inc. (NASDAQ:BLUE – Free Report) by 94.2% in the fourth quarter, Holdings Channel.com reports. The firm owned 14,703 shares of the biotechnology company’s stock after selling 237,359 shares during the quarter. Barclays PLC’s holdings in bluebird bio were worth $123,000 at the end of the most recent […]
